O
RVLP

OppenheimerFunds’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

OppenheimerFunds’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$140K Buy
38,890
+5,416
+16% +$39.9K ﹤0.01% 1727
2018
Q4 		$259K Buy
+33,474
New +$268K ﹤0.01% 1638

Other funds holding RVLP

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

OppenheimerFunds's RVLP Position: Q1 2019 in Review

OppenheimerFunds increased its RVL Pharmaceuticals plc Ordinary Shares (RVLP) stake by 16% in Q1 2019, buying an estimated $39.9K and bringing the position to 38,890 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #1727.

OppenheimerFunds first reported a position in RVLP in Q4 2018 and has held it in 2 quarters since. The position peaked at $259K in Q4 2018. 36 funds tracked by Wall St. Rank hold RVLP as of Q1 2019.

  • OppenheimerFunds held 38,890 shares of RVL Pharmaceuticals plc Ordinary Shares worth $140K as of Q1 2019.
  • OppenheimerFunds bought 5,416 RVL Pharmaceuticals plc Ordinary Shares shares in Q1 2019, an estimated $39.9K.
  • RVL Pharmaceuticals plc Ordinary Shares made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1727 holding.
  • OppenheimerFunds first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2018 and has held it in 2 quarters since.
  • OppenheimerFunds's RVL Pharmaceuticals plc Ordinary Shares position peaked at $259K in Q4 2018.
  • 36 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.